The number of new drugs specifically for pediatric cancer can be counted on one hand – yet so much progress has been made in treating children's cancer in the last few decades! Since the mid-70s, five-year survival rates have gone from 58% of patients to 85% of patients.
Leading the charge here at Hollings is Dr. Michelle Hudspeth. “People want to understand, ’Why did it happen?’ So, I really address that with parents.,” said Hudspeth. “I tell them it's really critical that you understand this isn't because of something you did or because of something you didn't do. It just is. That’s a really hard thing to accept.”
Dr. Michelle Hudspeth joins Hollings director Dr. Raymond N. DuBois to talk about the highs and lows of treating children with cancer.
![](https://i.ytimg.com/vi/jHdHbqDw8xM/mqdefault.jpg)